Feb 22
|
Prothena Full Year 2024 Earnings: Misses Expectations
|
Feb 21
|
Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus
|
Feb 21
|
Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ...
|
Feb 20
|
Prothena (PRTA) Reports Q4 Loss, Misses Revenue Estimates
|
Feb 20
|
Prothena: Q4 Earnings Snapshot
|
Feb 20
|
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights
|
Feb 13
|
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
|
Dec 30
|
Prothena Announces Board of Directors Update
|
Sep 25
|
Eli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan
|
Aug 18
|
Prothena Corporation plc (PTRA): Positioning Among Top Debt-Free Stocks
|
Jul 29
|
Merus N.V. (MRUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
Jul 25
|
Prothena (PRTA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
|
Jun 24
|
Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last?
|
Jun 24
|
Here's Why We're Not Too Worried About Prothena's (NASDAQ:PRTA) Cash Burn Situation
|
May 14
|
News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA) Forecasts
|
May 12
|
Analysts Have Lowered Expectations For Prothena Corporation plc (NASDAQ:PRTA) After Its Latest Results
|
May 9
|
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
|
May 8
|
Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates
|
May 8
|
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
|
May 8
|
We think Prothena Corporation plc's (NASDAQ:PRTA) CEO May Struggle To See Much Of A Pay Rise This Year
|